Related Experiment Video

Updated: Jun 12, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Methotrexate disposition in humans: case studies in ovarian cancer and following high-dose infusion

B A Chabner, R G Stoller, K Hande

    Drug Metabolism Reviews
    |January 1, 1978
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
    10:58

    Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

    Published on: July 18, 2016

    Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
    09:40

    Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

    Published on: August 2, 2024

    Related Experiment Videos

    Last Updated: Jun 12, 2026

    Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
    08:55

    Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

    Published on: November 2, 2014

    Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
    10:58

    Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

    Published on: July 18, 2016

    Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
    09:40

    Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

    Published on: August 2, 2024

    Related Concept Videos

    Therapeutic Drug Monitoring: Affecting Factors01:29

    Therapeutic Drug Monitoring: Affecting Factors

    Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

    Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

    Articles linked to this work by shared authors, journal, and citation graph.

    Cytidine and deoxycytidylate deaminase inhibition by uridine analogs.

    Biochemical pharmacology·2010

    Complementary, alternative, integrative, or unconventional medicine?

    The oncologist·2001

    Losing God.

    The oncologist·2001

    Caring for colleagues.

    The oncologist·2001

    Medical mistakes: a workshop on personal perspectives.

    The oncologist·2001

    Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000

    Physical Organic Chemistry in Biochemical Toxicology and the Career of Robert P. "Bob" Hanzlik.

    Drug metabolism reviews·2026

    Reprogramming of hepatic drug metabolism following early-life xenobiotic exposure: insights from nuclear receptor pathways.

    Drug metabolism reviews·2026

    Metabolic pharmacology of anthelmintic drugs targeting mitochondrial fumarate reductase in neurocysticercosis.

    Drug metabolism reviews·2026

    Metabolism-driven hepatotoxicity of 5-fluorouracil: molecular mechanisms and future therapeutic directions.

    Drug metabolism reviews·2026

    SAR and mechanistic pathways of oxadiazole derivatives: targeting enzymes for antidiabetic therapy.

    Drug metabolism reviews·2026

    Bioactivation and reactivity research advances - 2025 year in review.

    Drug metabolism reviews·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us